Elanco Animal Health secured EU antitrust clearance on Monday to buy Bayer’s veterinary drugs unit after pledging to sell some products to address competition concerns about the US$7.6 billion deal.
Elanco wins conditional EU antitrust okay for US$7.6 billion Bayer deal
